Work

Efficacy and Safety of a New Selective Oral Factor Xa Inhibitor Amidine Hydrochloride for Prevention of Thromboembolic Events in Hospitalized Patients with COVID-19: a Multiple-Center Prospective Randomized Controlled Study

Year: 2024

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Venous Disorders

DOI: 10.17116/flebo202418021154

Authors: I.A. Suchkov, N.D. Mzhavanadze, A.A. Shuldyakov, Z.G. Tatarintseva, N.V. Kirichenko, D.A. Sychev, L.K. Brizhan, O.E. Balashov, A.A. Chobanian, D.A. Maksaev, N.Yu. Pshenichnaya, N.V. Lomakin

Institutions: Ryazan State Medical University named after Academician I.P. Pavlov, Saratov State Medical University, Russian Medical Academy of Continuous Professional Education, Central Research Institute of Epidemiology

Language: English

Topic: Venous Thromboembolism Diagnosis and Management

Subfield: Internal Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4399745935

FWCI: 0.751

Cites: 10

Cited by: 2

Related to: 10